Ezawa S - Search Results

1

A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma.

Suzuki N, Aoki D, Oie S, Horiuchi M, Hasegawa Y, Ezawa S, Suzuki A, Susumu N, Hosoi F, Kitazato K, Nozawa S. Suzuki N, et al. Among authors: ezawa s. Gynecol Oncol. 2004 Sep;94(3):643-9. doi: 10.1016/j.ygyno.2004.06.026. Gynecol Oncol. 2004. PMID: 15350353

2

Loss of integrin alpha3 expression associated with acquisition of invasive potential by ovarian clear cell adenocarcinoma cells.

Suzuki N, Higashiguchi A, Hasegawa Y, Matsumoto H, Oie S, Orikawa K, Ezawa S, Susumu N, Miyashita K, Aoki D. Suzuki N, et al. Among authors: ezawa s. Hum Cell. 2005 Sep;18(3):147-55. doi: 10.1111/j.1749-0774.2005.tb00005.x. Hum Cell. 2005. PMID: 17022147

3

A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: potential new therapy for ovarian clear cell adenocarcinoma.

Ezawa S, Suzuki N, Ohie S, Higashiguchi A, Hosoi F, Kitazato K, Susumu N, Aoki D. Ezawa S, et al. Gynecol Oncol. 2008 Mar;108(3):627-31. doi: 10.1016/j.ygyno.2007.10.019. Epub 2007 Nov 28. Gynecol Oncol. 2008. PMID: 18048092

4

Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer.

Nomura H, Aoki D, Suzuki N, Susumu N, Suzuki A, Tamada Y, Kataoka F, Higashiguchi A, Ezawa S, Nozawa S. Nomura H, et al. Among authors: ezawa s. Int J Gynecol Cancer. 2006 Mar-Apr;16(2):799-804. doi: 10.1111/j.1525-1438.2006.00529.x. Int J Gynecol Cancer. 2006. PMID: 16681764

5

Intermittent pneumatic compression for prevention of pulmonary thromboembolism after gynecologic surgery.

Suzuki N, Kataoka F, Higashiguchi A, Hirao T, Ezawa S, Nomura H, Tomita A, Susumu N, Aoki D. Suzuki N, et al. Among authors: ezawa s. Thromb J. 2005 Nov 19;3:18. doi: 10.1186/1477-9560-3-18. Thromb J. 2005. PMID: 16297244 Free PMC article.

6

Treatment of endometrial hyperplasia with a danazol-releasing intrauterine device: a prospective study.

Tamaoka Y, Orikasa H, Sumi Y, Sakakura K, Kamei K, Nagatani M, Ezawa S. Tamaoka Y, et al. Among authors: ezawa s. Gynecol Obstet Invest. 2004;58(1):42-8. doi: 10.1159/000077882. Epub 2004 Apr 14. Gynecol Obstet Invest. 2004. PMID: 15087596

7

Direct effect of danazol on endometrial hyperplasia in adenomyotic women: treatment with danazol containing intrauterine device.

Tamaoka Y, Orikasa H, Sumi Y, Sakakura K, Kamei K, Nagatani M, Ezawa S. Tamaoka Y, et al. Among authors: ezawa s. Hum Cell. 2000 Sep;13(3):127-33. Hum Cell. 2000. PMID: 11197774 Clinical Trial.

8

Response of glassy-cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C.

Mikami M, Ezawa S, Sakaiya N, Komuro Y, Tei C, Fukuchi T, Mukai M. Mikami M, et al. Among authors: ezawa s. Lancet. 2000 Apr 1;355(9210):1159-60. doi: 10.1016/S0140-6736(00)02070-5. Lancet. 2000. PMID: 10791384

9

Sensing Algorithm to Estimate Slight Displacement and Posture Change of Target from Monocular Images.

Ito T, Yoneyama H, Akiyama Y, Hagiwara T, Ezawa S. Ito T, et al. Among authors: ezawa s. Sensors (Basel). 2023 Jan 11;23(2):851. doi: 10.3390/s23020851. Sensors (Basel). 2023. PMID: 36679648 Free PMC article.

10

Effects of hot‑water extracts from 26 herbs on α‑glucosidase activity.

Kikuchi H, Toyoda N, Ezawa S, Yoshida S, Hibino Y, Sunaga K. Kikuchi H, et al. Among authors: ezawa s. Mol Med Rep. 2020 Oct;22(4):3525-3532. doi: 10.3892/mmr.2020.11397. Epub 2020 Jul 31. Mol Med Rep. 2020. PMID: 32945423

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters